A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
Clinical trial NCT04351555 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04351555
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2024-10-15
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.